← Human Trials & Peer-Reviewed Studies
Effectiveness of Prenatal Vitamin D Deficiency Screening and Treatment Program: A Stratified Randomized Field Trial.
Plain-language guide to PMID 29788364 (2018): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 800 women.
Key Facts
- PMID
- 29788364
- Journal
- The Journal of clinical endocrinology and metabolism
- Year
- 2018
- Study type
- Randomized Controlled Trial
- Authors
- Rostami M et al. (7 authors)
- DOI
- 10.1210/jc.2018-00109
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.
Despite evidence on the association between hypovitaminosis D and adverse pregnancy outcomes and the positive impact of vitamin D supplementation, no evidence exists supporting a universal screening program in pregnancy as part of routine prenatal care.
Who Took Part
The study group was 800 women.
The age groups tagged for this paper are teenagers, young adults and adults, women only.
Within the screening arm, a randomized controlled trial was conducted on 800 pregnant women.
Pregnant women aged 18 to 40 years.
How the Study Was Run
The design is described as randomized.
Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.
Two cities of Masjed-Soleyman and Shushtar from Khuzestan province, Iran, were selected as the screening and nonscreening arms, respectively.
Health centers of Masjed-Soleyman and Shushtar cities.
Women with moderate [25(OH)D, 10 to 20 ng/mL] and severe [25(OH)D, <10 ng/mL] deficiency were randomly divided into four subgroups and received vitamin D3 (D3) until delivery.
What Was Measured
Despite evidence on the association between hypovitaminosis D and adverse pregnancy outcomes and the positive impact of vitamin D supplementation, no evidence exists supporting a universal screening program in pregnancy as part of routine prenatal care.
The subject headings attached to it are Cholecalciferol, Dietary Supplements, Pregnancy Complications, Pregnancy Outcome, Prenatal Diagnosis, Program Evaluation and Vitamin D Deficiency.
What This Means in Plain Language
The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc in 800 women.
With several hundred people or more, it is a fairly large study for this kind of research.
Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2018 (The Journal of clinical endocrinology and metabolism), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.